ID   HR
AC   CVCL_ZE74
DR   Wikidata; Q98126708
RX   PubMed=3791243;
RX   PubMed=6541042;
CC   Population: Japanese.
CC   Doubling time: 13.2 hours (PubMed=3791243); 19 hours (PubMed=6541042).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
RX   PubMed=3791243;
RA   Kikuchi Y., Kizawa I., Oomori K., Miyauchi M., Kita T., Sugita M.,
RA   Tenjin Y., Kato K.;
RT   "Establishment of a human ovarian cancer cell line capable of forming
RT   ascites in nude mice and effects of tranexamic acid on cell
RT   proliferation and ascites formation.";
RL   Cancer Res. 47:592-596(1987).
//
RX   PubMed=6541042; DOI=10.1016/0006-291x(84)90425-x;
RA   Kikuchi Y., Iwano I., Kato K.;
RT   "Effects of calmodulin antagonists on human ovarian cancer cell
RT   proliferation in vitro.";
RL   Biochem. Biophys. Res. Commun. 123:385-392(1984).
//